Navigation Links
Omega Protein Reports 17 Cents Per Share Third Quarter Profit
Date:11/10/2008

HOUSTON, Nov. 10 /PRNewswire-FirstCall/ -- Omega Protein Corporation (NYSE: OME), the nation's leading producer of Omega-3 fish oil and specialty fish meal products, today reported net income of $3.1 million (17 cents a share) for the third quarter of 2008, compared to net income of $7.2 million (42 cents a share) for the third quarter of the previous year.

(Logo: http://www.newscom.com/cgi-bin/prnh/20030516/OMEGALOGO)

Revenues for the third quarter ended September 30, 2008 were $54.5 million compared with revenues of $44.6 million for the comparable quarter in 2007. Omega Protein recorded operating income of $5.3 million for the 2008 third quarter, versus operating income of $12.3 million for the third quarter of 2007.

For the nine months ended September 30, 2008, the Company had revenues of $137.7 million, compared with $112.8 million in revenues for the first nine months of 2007. Omega Protein recorded operating income of $21.0 million for the nine months ended September 30, 2008, versus operating income of $18.6 million for the comparable period a year earlier. The Company had net income of $11.7 million ($0.65 per share) for the nine months ended September 30, 2008, compared with net income of $7.4 million ($0.44 per share) for the nine months ended September 30, 2007.

As previously reported, during the quarter ended September 30, 2008, the Company suffered wind and flood damages to two of its facilities as a result of Hurricane Ike. The Company's Abbeville, Louisiana facility was restored to full capacity within a few weeks. The Company's Cameron, Louisiana facility is continuing its repairs and is expected to be fully funct
'/>"/>

SOURCE Omega Protein Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. Omega-3s Guard Against Type 1 Diabetes
2. Brain, Eye and Heart Health: Three Reasons to Eat More Omega-3s
3. Maine Natural Health Company Brings Omega-3 Benefits to Pets
4. Nordic Naturals Introduces Ultimate Omega 500 - Their Best Selling Formula Now Available in a Smaller Size Soft Gel!
5. Omega-3s Linked to Prevention of Parkinsons Disease and More
6. Nordic Naturals Professional Exclusive Division Redefines High Potency Omega-3 Supplementation With New Elite Line!
7. Ongoing Tests Show Kona Kampachi(R) is Rich in Omega-3s With No Detectable Mercury
8. Mayo Clinic proceedings highlights research about cardiovascular benefits of omega-3 fatty acids
9. Omega Protein Reports 2007 Results
10. Infant formula must contain DHA omega-3 and AA omega-6, say international experts
11. Omega-3 Fatty Acids Protect the Spinal Cord, Heart, Brain and Eyes
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:183 New Medicines in Development for Diabetes 2Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 2Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 3Pro-Dex, Inc. Announces Results of Annual Shareholder Meeting, an Update Regarding Major Customer's Product Development Plans, and Receipt of $1.5 Million and $3.0 Million Purchase Orders 4Maxygen, Inc. Announces Extension of Dutch Auction Tender Offer 2Ikaria 28R 29 Names New Chairman 14523 1Ikaria 28R 29 Names New Chairman 14523 2Antibiotic Resistant Infections Cost the U S Healthcare System in Excess of 2420 Billion Annually 5561 1Antibiotic Resistant Infections Cost the U S Healthcare System in Excess of 2420 Billion Annually 5561 2Antibiotic Resistant Infections Cost the U S Healthcare System in Excess of 2420 Billion Annually 5561 3Antibiotic Resistant Infections Cost the U S Healthcare System in Excess of 2420 Billion Annually 5561 4Antibiotic Resistant Infections Cost the U S Healthcare System in Excess of 2420 Billion Annually 5561 5Antibiotic Resistant Infections Cost the U S Healthcare System in Excess of 2420 Billion Annually 5561 6Antibiotic Resistant Infections Cost the U S Healthcare System in Excess of 2420 Billion Annually 5561 7Jennerex Inc Receives EMEA Orphan Drug Designation for JX 594 for the Treatment of Hepatocellular Carcinoma 5557 1Jennerex Inc Receives EMEA Orphan Drug Designation for JX 594 for the Treatment of Hepatocellular Carcinoma 5557 2Jennerex Inc Receives EMEA Orphan Drug Designation for JX 594 for the Treatment of Hepatocellular Carcinoma 5557 3